Shaw, Founder and Executive Chairperson of Biocon, on catching up with China, the right recruitment policies, and more.
“Even after India approves the coronavirus vaccine, it might not be possible to produce more than 10-20 million doses in the first year.” The comments came from the Chairperson of Biocon in an ...
She founded the India-based pharma company Biocon with merely two employees and funds worth $500. In 2014, Biocon became the first biopharma company to be a publicly-traded entity and the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results